1-(hydroxymethyl)-5,5-dimethylhydantoin

Metabolite details

Identifier

SIQZJFKTROUNPI-UHFFFAOYSA-N

InChI Key

SIQZJFKTROUNPI-UHFFFAOYSA-N

IUPAC name

1-(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione

Preferred name

1-(hydroxymethyl)-5,5-dimethylhydantoin

INN name

—

Synonym

hydroxymethyl-5,5-dimethylhydantoin

ChEBI

CHEBI:143246

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Transcriptional memory of dFOXO activation in youth curtails later-life mortality
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• RU-_Control_vs_RU+_Switch
• G1_PBS_vs_G2_DSS
• Male_19_days_vs_Male_1_day
• wild_type_vs_patA_deletion